• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Endo Pharmaceutical Holdings

Endo Pharmaceutical Holdings

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Morganti Legal Announces Shareholder Investigation of Endo International plc

    Morganti Legal Announces Shareholder Investigation of Endo International plc

  2. January 6 Deadline Alert: Law Offices of Howard G. Smith Reminds Endo International plc Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm

    January 6 Deadline Alert: Law Offices of Howard G. Smith Reminds Endo International plc Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm

  3. GPM Reminds Investors of the January 6th Deadline in the Class Action Lawsuit Against Endo International plc and Encourages Investors to Contact the Firm

    GPM Reminds Investors of the January 6th Deadline in the Class Action Lawsuit Against Endo International plc and Encourages Investors to Contact the Firm

  4. The Market: Exaggerated Woes

    Endo Pharmaceuticals ENDP announced July 11 that it no longer expects to file a new drug application for its ketoprofen pain-relief patch by the first half of 2008 because of lackluster Phase III trial results. The drug candidate failed to show statistically significant results for pain relief in ...

  5. Health Care: 3 Picks in a More Expensive Sector

    Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.

  6. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

    Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.

  7. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

    As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.

  8. Our Outlook for the Credit Markets

    The corporate bond market will probably struggle to return much above break-even in 2014.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.